**Core Concept**
The patient's symptoms suggest a medication-induced vasoconstriction, leading to peripheral ischemia. This is a known side effect of certain medications, particularly those used to treat migraines.

**Why the Correct Answer is Right**
The symptoms described, including nausea, vomiting, tingling, numbness, and cyanosis (blue discoloration) of the fingers, are characteristic of a condition known as Raynaud's phenomenon. This condition is caused by vasospasm of the small blood vessels in the extremities, leading to reduced blood flow and oxygen delivery. The medication implicated in this case is likely ergotamine or a similar ergot alkaloid, which is known to cause vasoconstriction and is often used to treat migraines. The activation of 5-HT2 receptors by ergot alkaloids leads to the contraction of smooth muscle in blood vessels, resulting in the symptoms observed.

**Why Each Wrong Option is Incorrect**
**Option A:** While other medications can cause vasoconstriction, the specific combination of symptoms described is most closely associated with ergot alkaloids.
**Option B:** Triptans, such as sumatriptan, can cause vasoconstriction, but they are not typically associated with the same degree of peripheral ischemia as ergot alkaloids.
**Option C:** Metoclopramide can cause extrapyramidal side effects and other symptoms, but it is not typically associated with vasoconstriction or peripheral ischemia.
**Option D:** Other medications can cause nausea and vomiting, but the combination of symptoms described is most closely associated with ergot alkaloids.

**Clinical Pearl / High-Yield Fact**
Ergot alkaloids can cause a range of systemic effects, including vasoconstriction, due to their activation of 5-HT2 receptors. This can lead to symptoms such as peripheral ischemia, and in severe cases, can even cause gangrene.

**Correct Answer:** C. Metoclopramide